BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10316796)

  • 1. Evolution of a children's drug table.
    Shirkey HC
    Hosp Formul; 1979 Mar; 14(3):319-20, 325-6, 330. PubMed ID: 10316796
    [No Abstract]   [Full Text] [Related]  

  • 2. Method of the study.
    Stud Anc Med; 2009; 38():85-126. PubMed ID: 20481148
    [No Abstract]   [Full Text] [Related]  

  • 3. The United States Pharmacopeia. Its value to the professions.
    Heller WM
    JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287
    [No Abstract]   [Full Text] [Related]  

  • 4. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 5. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 6. Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?
    Monro A; Mehta D
    Clin Pharmacol Ther; 1996 Mar; 59(3):258-64. PubMed ID: 8653987
    [No Abstract]   [Full Text] [Related]  

  • 7. Historical background.
    Stud Anc Med; 2009; 38():9-63. PubMed ID: 20481146
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of USP-NF to NDA and ANDA "Standards".
    Belson JJ
    Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269
    [No Abstract]   [Full Text] [Related]  

  • 10. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 12. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical bases of drug action. Introduction].
    Büchi J
    Pharm Acta Helv; 1968 Jun; 43(6):321-30. PubMed ID: 4880600
    [No Abstract]   [Full Text] [Related]  

  • 14. Cough.
    Stud Anc Med; 2009; 38():225-82. PubMed ID: 20481150
    [No Abstract]   [Full Text] [Related]  

  • 15. Reporting drug defects.
    Belson JJ
    Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Difficulties in fixing the official dosage of drugs in children].
    Lechat P
    Therapie; 1989; 44(2):137-9. PubMed ID: 2756519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosebleed.
    Stud Anc Med; 2009; 38():127-224. PubMed ID: 20481149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pediatric dosages in the 3d edition of the Czechoslovakain Pharmacopoeia].
    Urbanec J; Raska B
    Cesk Farm; 1969 Mar; 18(2):94-7. PubMed ID: 5813625
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug product equivalence--the problem, the challenge, and the U.S.P.
    Macek TJ
    Am J Pharm Sci Support Public Health; 1971; 143(6):188-94. PubMed ID: 5140167
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug standards and the dental practitioner.
    Feldmann EG
    J Oral Ther Pharmacol; 1965 Nov; 2(3):224-8. PubMed ID: 5849261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.